HeyJaredThe Cure Circle
The Cure Circle is a global dialogue on regenerative medicine, cell and gene therapy, and the science of true healing.
- Indexed episodes, last 90 days
- 4
- Latest publication
- Sep 7, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 27, 2026
Latest episodes
From Science to Access: Building India’s Cell & Gene Therapy Future (opens the original)
Read excerpt
What will it take for India to build a cell and gene therapy ecosystem that can compete globally? In Episode 5 of The Cure Circle, host Dr. Smita Karpate, MD, speaks with Dr. Arun Anand, MD, a physician-executive, cell and gene therapy business leader, and nominated expert on the Precision Biotherapeutics Committee, Department of Biotechnology (DBT/BIRAC), Government of India. With more than two decades of experience, Dr. Arun brings a rare blend of clinical expertise, drug development, portfoli
Why India Loses Top Scientific Talent (opens the original)
Read excerpt
What slows cell and gene therapy, biology or systems? In this episode of The Cure Circle , translational immunotherapy researcher Gaurang Telang explains why reproducibility, documentation, and system reliability, not heroics, determine whether CAR-T science reaches patients. A grounded look at what real CGT translation requires. In Episode 4 of The Cure Circle , host Dr. Smita Karpate speaks with Gaurang Telang , a translational T-cell immunotherapy researcher at the Leibniz Institute for Immun
CAR-T Therapy in Multiple Myeloma: From Relapse to Real Hope (opens the original)
Read excerpt
In this episode of The Cure Circle , host Dr. Smita Karpate, MD, is joined by Dr. Mallikarjun Kalashetty , DM, Head of Clinical Hematology, Hemato-Oncology, Bone Marrow Transplantation, and Cellular Therapy at Manipal Hospitals , Bengaluru. Multiple myeloma remains one of the most complex and relentless blood cancers, treatable but rarely curable. While modern drug combinations and stem cell transplants have extended survival, relapse is inevitable for most patients. This is where CAR-T therapy
Why CMC and Manufacturing Decide CGT Success (opens the original)
Read excerpt
In this episode of The Cure Circle , host Dr. Smita Karpate, MD is joined by Emily Moran , Founder of 3LB Consulting , a global expert at the intersection of cell and gene therapy manufacturing, CMC strategy, and regulatory execution . While cell and gene therapies promise cures once thought impossible, most programs do not fail because of weak science — they fail because execution breaks down. Emily’s work focuses on closing that gap: translating beautiful biology into manufacturable, compliant
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.